Venofer denied as non-formulary by Cigna?

Cigna's specific coverage criteria for venofer are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied Venofer as Non-Formulary

Cigna structures its drug formulary by tier, and IV iron products may be placed on a non-preferred or non-formulary tier — or excluded from the formulary entirely — in favor of a different intravenous iron preparation that Cigna has designated as its preferred agent. A non-formulary denial does not mean Venofer (iron sucrose) is not covered under any circumstances; it means coverage requires either a formulary exception or demonstration that the preferred alternative is clinically inappropriate for this patient.

## Why This Denial Is Appealable

Formulary exceptions are a standard, well-established pathway: when the formulary alternative is contraindicated, has been tried and failed, or is otherwise clinically inappropriate for a specific patient, Cigna is required to consider coverage of the non-formulary drug. Additionally, if Cigna's preferred IV iron agent is not clinically equivalent to Venofer for this patient's specific indication or tolerability profile, that clinical distinction supports the exception. Non-formulary appeals with strong prescriber documentation have a meaningful success rate.

## Federal Appeal Framework

• Formulary exception request: This is the most direct first step — submit a formulary exception request with the prescriber's clinical rationale before or alongside the formal internal appeal. Cigna must respond within 72 hours for urgent requests.
• Internal appeal: File within the deadline on the denial notice. Cigna must respond within 30 days (pre-service) or 60 days (post-service).
• External review (ACA §2719 / ERISA §503): After a final adverse internal decision, request IRO external review within approximately 4 months. The IRO's decision is binding on Cigna.

## Documentation to Gather

• Formulary alternative trial history: If Cigna's preferred IV iron product was tried, chart documentation of dates, response, and reason for switching to Venofer.
• Clinical rationale for Venofer specifically: Prescriber explanation of why iron sucrose is the appropriate formulation for this patient — addressing tolerability, infusion characteristics, or indication-specific clinical evidence.
• Diagnosis and lab documentation: Confirmation of the underlying diagnosis and iron-deficiency severity supporting IV iron use generally.
• Prescriber medical-necessity letter: A letter explaining both why IV iron is required and why the formulary preferred alternative is not appropriate for this specific patient.

## Criteria-Mapping Structure

Obtain Cigna's formulary exception criteria from their published coverage policy or summary plan description. List each criterion that must be met for a non-formulary exception. For each criterion, cite the specific chart note, trial record, or prescriber statement that satisfies it. This structured mapping is your most persuasive tool in a formulary exception appeal.